Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas (Q44179348)

30 November 2017

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas (English)

1 reference

30 November 2017

Anthony P Heaney

1

1 reference

30 November 2017

Manory Fernando

series ordinal

2

1 reference

30 November 2017

William H Yong

series ordinal

3

1 reference

30 November 2017

Shlomo Melmed

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

15 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

8

1 reference

30 November 2017

1281-1287

1 reference

30 November 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm784

30 November 2017

0 references

cites work

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

1 reference

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

21 January 2018

1 reference

Novel sequence determinants in peroxisome proliferator signaling

21 January 2018

1 reference

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo

21 January 2018

1 reference

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

Guidelines for acromegaly management

21 January 2018

1 reference

Antiarrhythmic agents in facilitating electrical cardioversion of atrial fibrillation and promoting maintenance of sinus rhythm

21 January 2018

1 reference

Transsphenoidal microsurgery for Cushing disease. A report of 216 cases

21 January 2018

1 reference

Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery

21 January 2018

1 reference

Diagnosis and differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas.

21 January 2018

1 reference

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

ACTH precursors: biological significance and clinical relevance

21 January 2018

1 reference

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells

21 January 2018

1 reference

Troglitazone suppresses cell growth of myeloid leukemia cell lines by induction of p21WAF1/CIP1 cyclin-dependent kinase inhibitor

21 January 2018

1 reference

Pituitary-specific and hormonally regulated gene expression directed by the rat proopiomelanocortin promoter in transgenic mice.

21 January 2018

1 reference

Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing

21 January 2018

1 reference

Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis

21 January 2018

1 reference

The use of ketoconazole as an inhibitor of steroid production

21 January 2018

1 reference

Peroxisome proliterator-activated receptors, orphans with ligands and functions

21 January 2018

1 reference

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

21 January 2018

1 reference

Cushing's syndrome--killing disease: discriminatory value of signs and symptoms aiding early diagnosis

21 January 2018

1 reference

Management of pituitary tumors

21 January 2018

1 reference

21 January 2018

1 reference

Cyproheptadine-Induced Remission of Cushing's Disease

21 January 2018

1 reference

Regulation of TRAIL-induced apoptosis by transcription factors

21 January 2018

1 reference

Serum cortisol response to transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM784

1 reference

30 November 2017

1 reference